Citation Impact
Citing Papers
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study
1998
Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort
2015
Transient Ablation of Regulatory T cells Improves Antitumor Immunity in Colitis-Associated Colon Cancer
2014 StandoutNobel
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Endoscopy in Inflammatory Bowel Disease
2007
Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low
2000
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
2001 Standout
A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease
2000
Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis
2003
Cancer in inflammatory bowel disease
2008
Cancer risk in patients with inflammatory bowel disease
2001 Standout
Higher Incidence of Abnormal Pap Smears in Women With Inflammatory Bowel Disease
2007
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Colonoscopic polypectomy in chronic colitis: Conservative management after endoscopic resection of dysplastic polyps
1999
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
Management of Crohn's disease in adults
2001
Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort Study
2007
Review article: monitoring of immunomodulators in inflammatory bowel disease
2005
Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohnʼs disease of the colon
2008
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
2011 Standout
Quality indicators for colonoscopy
2006
Microsatellite Instability in Colorectal Cancer
2010 Standout
The Pharmacogenetics of Immunosuppression for Organ Transplantation
2003
A Prospective Randomized Observer-Blind 2-Year Trial of Azathioprine Monotherapy versus Azathioprine and Olsalazine for the Maintenance of Remission of Steroid-Dependent Ulcerative Colitis
2004
Two stage genome–wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12
1996
The fate of low grade dysplasia in ulcerative colitis
2002
The incidence of cancer associated with the treatmentof rheumatoid arthritis
1999
Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County
2004
Ulcerative Colitis
2011 Standout
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
2000 Standout
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Tolerability and safety of mercaptopurine in azathioprine‐intolerant patients with inflammatory bowel disease
2007
A Meta-Analysis of the Yield of Capsule Endoscopy Compared to Other Diagnostic Modalities in Patients with Non-Stricturing Small Bowel Crohn's Disease
2006
The relationship between infliximab treatment and lymphoma in Crohn's disease
1999
Case Report: Acute Myeloblastic Leukemia Following Prolonged Treatment of Crohn's Disease with 6-Mercaptopurine
1998
Azathioprine for maintenance of remission in Crohn's disease: Benefits outweigh the risk of lymphoma
2000
A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on Azathioprine
2005
Infections and IBD
2008
AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease
2010
the risks of malignancy from either immuno‐suppression or diagnostic radiation in inflammatory bowel disease
1995
Guidelines for the management of inflammatory bowel disease in adults
2011
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)
2010
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease
1998
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Comparative Tolerability of Treatments for Inflammatory Bowel Disease
2000
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Genetic pathways in colorectal and other cancers
1999
Crohn's disease
2012 Standout
Low-dose 6-mercaptopurine in inflammatory bowel disease is associated with minimal hematologic toxicity
1994
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
2017 Standout
Efficacy and safety of repeated infliximab infusions for Crohn's disease: 1-year clinical experience
2001
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
2001 StandoutNature
Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD
2007
Malignant Neoplasms Subsequent to Treatment of Inflammatory Bowel Disease With 6-Mercaptopurine
1999
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
1997 Standout
Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis
2003
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Inflammatory Bowel Disease
2009 Standout
Olsalazine and 6-mercaptopurine-related bone marrow suppression: A possible drug-drug interaction
1997
Thiopurine-Induced Myelotoxicity in Patients With Inflammatory Bowel Disease: A Review
2008
The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review
2002
Risks and Benefits of Infliximab for the Treatment of Crohn’s Disease
2006
Inflammatory bowel disease is not associated with an increased risk of lymphoma
2001
Genetic Susceptibility for Human Familial Essential Hypertension in a Region of Homology with Blood Pressure Linkage on Rat Chromosome 10
1997 StandoutNobel
Activation-Induced Cytidine Deaminase Links Between Inflammation and the Development of Colitis-Associated Colorectal Cancers
2008 StandoutNobel
Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
2007
Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin
2008
Incidence and Prevalence of Crohn’s Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010
2016
A Cost-Effectiveness Analysis of Alternative Disease Management Strategies in Patients with Crohn's Disease Treated with Azathioprine or 6-Mercaptopurine
2005
Azathioprine: State of the Art in Inflammatory Bowel Disease
1998
Ulcerative colitis
2012 Standout
Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment
2006
10 Adjuvant post-operative therapy
1998
Most dysplasia in ulcerative colitis is visible at colonoscopy
2004
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
2004 Standout
Crohn's disease
2016 Standout
Inflammatory Bowel Disease
2002 Standout
Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta-analysis of Population-Based Studies
2013
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
2000
Consensus Conference: Colorectal Cancer Screening and Surveillance in Inflammatory Bowel Disease
2005
Twenty Years' Colonoscopic Surveillance of Patients with Ulcerative Colitis Detection of Dysplastic and Malignant Transformation
1996
Endoscopy in inflammatory bowel disease: Indications, surveillance, and use in clinical practice
2005
Thirty-Year Analysis of a Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis
2006
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002 Standout
European evidence-based Consensus on the management of ulcerative colitis: Special situations
2008
Capsule Endoscopy Has a Significantly Higher Diagnostic Yield in Patients With Suspected and Established Small-Bowel Crohn's Disease: A Meta-Analysis
2009
ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease
2006
Maintenance Treatment With Azathioprine in Ulcerative Colitis: Outcome and Predictive Factors After Drug Withdrawal
2009
Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview
2015
New Concepts in Intestinal Imaging for Inflammatory Bowel Diseases
2011
Hereditary Colorectal Cancer
2003 Standout
Ulcerative colitis
2016 Standout
How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance
2000
Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease
2013
Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis
2004
Inflammatory Bowel Disease
1996
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
2010
6-Mercaptopurine Metabolite Levels in Children With Inflammatory Bowel Disease
2001
Diagnosis and management of dysplasia in patients with inflammatory bowel diseases
2004
Adverse Events Associated With Common Therapy Regimens for Moderate-to-Severe Crohn's Disease
2009
Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database
2016
Screening and surveillance colonoscopy in chronic Crohn's colitis
2001
Review article: thiopurines in inflammatory bowel disease
2006
MEDICAL THERAPY FOR INFLAMMATORY BOWEL DISEASE
1999
Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case–Control Study of Middle Eastern Migration to Australia
2015
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease
1999
The gut microbiota — masters of host development and physiology
2013 Standout
Practice Guidelines for Inflammatory Bowel Disease: An Instrument for Assessment
1999
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
2017 Standout
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
2005
Current and future diagnostic approaches: From serologies to imaging
2007
Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug Administration
2002
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Lymphoma risk in inflammatory bowel disease: Is it the disease or its treatment?
2007
Inflammatory bowel disease: Etiology and pathogenesis
1998 Standout
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
2004
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
2010
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Cancer surveillance in inflammatory bowel disease
1999
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
2012 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Management of Crohn's Disease in Adults
2009 Standout
Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis
1999
Supporting the Health Care Transition From Adolescence to Adulthood in the Medical Home
2018
Guidelines for the management of inflammatory bowel disease in adults
2004
Video Capsule Endoscopy in Patients With Known or Suspected Small Bowel Stricture Previously Tested With the Dissolving Patency Capsule
2007
Risk Factors and Distinguishing Features of Cancer in IBD
1998
Endoscopic evaluation of patients with inflammatory bowel disease
2008
Evaluation of The Usefulness of Testing for P53 Mutations in Colorectal Cancer Surveillance for Ulcerative Colitis
1999
Epstein-Barr virus–positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine
2002
Prognosis of colorectal cancer varies in different high-risk conditions
1998
Surveillance Issues in Inflammatory Bowel Disease
2001
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration.
1996
Colorectal cancer screening and surveillance: Clinical guidelines and rationale?Update based on new evidence
2003 Standout
Increased susceptibility to colitis and colorectal tumors in mice lacking core 3–derived O-glycans
2007
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Quality Indicators for Colonoscopy
2014
Never underestimate inflammatory bowel disease: High prevalence rates and confirmation of high incidence rates in Australia
2015
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis
1998
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Meta-Analysis of Risk of Malignancy with Immunosuppressive Drugs in Inflammatory Bowel Disease
2007
Quality Indicators for Colonoscopy
2006
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis
2016
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Meta‐analysis: cancer risk of low‐grade dysplasia in chronic ulcerative colitis
2007
Quality indicators for colonoscopy
2014 Standout
Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
2009
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
2015
Anti-TNF Therapy and Malignancy – A Critical Review
2001
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease
2006
Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer
2001
Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine
1996
Disability in Patients with Inflammatory Bowel Disease: Correlations with Quality of Life and Patient’s Characteristics
2017
Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis
2004
Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management
2012 Standout
Works of William Connell being referenced
Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis.
1994
Lower gastrointestinal malignancy in Crohn's disease.
1994
Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease
1994
Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis
1994
Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis
2015
Altered Immune System Glycosylation Causes Colitis in α1,2-Fucosyltransferase Transgenic Mice
2004
High incidence of inflammatory bowel disease in Australia: A prospective population-based Australian incidence study
2010
Cerebral venous thrombosis associated with ulcerative colitis
2008
Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.
1993
Development and validation of a patient‐reported disability measurement tool for patients with inflammatory bowel disease
2012
Capsule endoscopy vs. push enteroscopy and enteroclysis in suspected small-bowel Crohn's disease
2005
8 Safety of corticosteroids and immunosuppressive agents in ulcerative colitis
1997
Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel disease
2014
P621 The natural history of inflammatory bowel disease (IBD) in an Australian based community cohort: investigating predictors of severe disease and risk of complications
2013